Literature DB >> 11254383

Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.

A L Gall1, M Ruff, R Kannan, P Cuniasse, A Yiotakis, V Dive, M C Rio, P Basset, D Moras.   

Abstract

Stromelysin-3 (ST3) is a matrix metalloproteinase (MMP-11) whose proteolytic activity plays an important role in tumorigenicity enhancement. In breast cancer, ST3 is a bad prognosis marker: its expression is associated with a poor clinical outcome. This enzyme therefore represents an attractive therapeutic target. The topology of matrix metalloproteinases (MMPs) is remarkably well conserved, making the design of highly specific inhibitors difficult. The major difference between MMPs lies in the S(1)' subsite, a well-defined hydrophobic pocket of variable depth. The present crystal structure, the first 3D-structure of the ST3 catalytic domain in interaction with a phosphinic inhibitor mimicking a (d, l) peptide, clearly demonstrates that its S(1)' pocket corresponds to a tunnel running through the enzyme. This open channel is filled by the inhibitor P(1)' group which adopts a constrained conformation to fit this pocket, together with two water molecules interacting with the ST3-specific residue Gln215. These observations provide clues for the design of more specific inhibitors and show how ST3 can accommodate a phosphinic inhibitor mimicking a (d, l) peptide. The presence of a water molecule interacting with one oxygen atom of the inhibitor phosphinyl group and the proline residue of the Met-turn suggests how the intermediate formed during proteolysis may be stabilized. Furthermore, the hydrogen bond distance observed between the methyl of the phosphinic group and the carbonyl group of Ala182 mimics the interaction between this carbonyl group and the amide group of the cleaved peptidic bond. Our crystal structure provides a good model to study the MMPs mechanism of proteolysis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254383     DOI: 10.1006/jmbi.2001.4493

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

Review 2.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

3.  Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.

Authors:  Janelle Lauer-Fields; Keith Brew; John K Whitehead; Shunzi Li; Robert P Hammer; Gregg B Fields
Journal:  J Am Chem Soc       Date:  2007-08-02       Impact factor: 15.419

4.  Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.

Authors:  Seakwoo Lee; Hyun I Park; Qing-Xiang Amy Sang
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

Review 5.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

6.  Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1' loop canonical conformation.

Authors:  Laurent Devel; Sandra Garcia; Bertrand Czarny; Fabrice Beau; Evelyne LaJeunesse; Laura Vera; Dimitris Georgiadis; Enrico Stura; Vincent Dive
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

Review 7.  Synthesis and biological applications of collagen-model triple-helical peptides.

Authors:  Gregg B Fields
Journal:  Org Biomol Chem       Date:  2010-01-20       Impact factor: 3.876

8.  Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.

Authors:  Jun Yong Choi; Rita Fuerst
Journal:  Methods Mol Biol       Date:  2017

9.  Computer modeling and nanosecond simulation of the enzyme-substrate complex of the common lymphoblastic leukemia antigen (neprilysin) indicates shared residues at the primary specificity pocket (S1') with matrix metalloproteases.

Authors:  Sergio Manzetti
Journal:  J Mol Model       Date:  2003-08-29       Impact factor: 1.810

10.  Interdomain flexibility in full-length matrix metalloproteinase-1 (MMP-1).

Authors:  Ivano Bertini; Marco Fragai; Claudio Luchinat; Maxime Melikian; Efstratios Mylonas; Niko Sarti; Dmitri I Svergun
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.